Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
0 this month

Showing 8081–8100 of 17,529 recalls

September 25, 2018· Right Value Drug Stores, Inc.

Recalled Item: Progesterone SR 100 mg Capsules

The Issue: Labeling Not Elsewhere Classified: Misbranding

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
September 25, 2018· RXQ Compounding LLC

Recalled Item: Lidocaine 1% + Epinephrine 1:100

The Issue: Subpotent drug: During testing of the retention sample,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 25, 2018· Baxter Healthcare Corporation

Recalled Item: Levofloxacin Injection in 5% Dextrose

The Issue: Superpotent Drug: High out of specification results for

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
September 21, 2018· Dr. Reddy's Laboratories, Inc.

Recalled Item: Nystatin and Triamcinolone Acetonide Cream

The Issue: Failed stability specifications - An out of specification

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 21, 2018· Teva Pharmaceuticals USA

Recalled Item: Clozapine Orally Disintegrating Tablets

The Issue: Failed Disintegration Specifications: Out-of-specification disintegration test r

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 20, 2018· Pfizer Inc.

Recalled Item: Meropenem for Injection

The Issue: Lack of assurance of sterility: loss of container

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 20, 2018· Teva Pharmaceuticals USA

Recalled Item: Clonazepam Orally Disintegrating Tablets USP

The Issue: Failed Stability Specifications: Out-of-specification test result for water

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 20, 2018· Pfizer Inc.

Recalled Item: Glipizide XL (glipizide) extended-release tablets 5 mg 500-tablet bottle

The Issue: CGMP Deviations; rejected product was used to manufacture

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 19, 2018· Upsher Smith Laboratories, Inc.

Recalled Item: Bumetanide Tablets

The Issue: Failed impurities/ degradation specifications: Product is Out of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 19, 2018· Upsher Smith Laboratories, Inc.

Recalled Item: Bumetanide Tablets

The Issue: Failed impurities/ degradation specifications: Product is Out of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 19, 2018· Pfizer Inc.

Recalled Item: Elelyso (taliglucerase alfa) for injection

The Issue: Lack of assurance of sterility -Reports of loose

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 18, 2018· Xiromed LLC

Recalled Item: Altavera Levonorgestrel and Ethinyl Estradiol Tablets

The Issue: Mislabeling

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
September 17, 2018· Medline Industries Inc

Recalled Item: SparkleFresh Fluoride Toothpaste

The Issue: Microbial Contamination of Non-Sterile Product

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
September 17, 2018· Endo Pharmaceuticals, Inc.

Recalled Item: robaxin-750 (methocarbamol tablets

The Issue: Labeling: Incorrect Instructions: Dosage information on the immediate

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
September 17, 2018· Otsuka Pharmaceutical Development & Commercialization, Inc.

Recalled Item: treatNOW ABILIFY (aripiprazole) / ABILIFY MAINTENA 400-mg (aripiprazole) for...

The Issue: Mislabeling

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
September 17, 2018· Otsuka Pharmaceutical Development & Commercialization, Inc.

Recalled Item: treatNOW ABILIFY (aripiprazole) and ABILIFY MAINTENA (aripiprazole) 400MG...

The Issue: Mislabeling

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
September 12, 2018· Dr. Reddy's Laboratories, Inc.

Recalled Item: Zoledronic Acid Injection

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
September 12, 2018· Dr. Reddy's Laboratories, Inc.

Recalled Item: Zoledronic Acid Injection

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
September 12, 2018· Hetero Labs, Ltd. - Unit III

Recalled Item: Fenofibrate Tablets

The Issue: Presence of Foreign Tablet/Capsule: A foreign identified as

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
September 11, 2018· Torrent Pharma Inc.

Recalled Item: Lamotrigine Extended-Release Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund